These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin. Sanz EJ, Villén T, Alm C, Bertilsson L. Clin Pharmacol Ther; 1989 May; 45(5):495-9. PubMed ID: 2721104 [Abstract] [Full Text] [Related]
34. Polymorphic hydroxylation of debrisoquine. Tucker GT, Silas JH, Iyun AO, Lennard MS, Smith AJ. Lancet; 1977 Oct 01; 2(8040):718. PubMed ID: 71525 [No Abstract] [Full Text] [Related]
35. Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism. Roy SD, Hawes EM, Hubbard JW, McKay G, Midha KK. Lancet; 1984 Dec 15; 2(8416):1393. PubMed ID: 6150386 [No Abstract] [Full Text] [Related]
36. [Relationship between amitriptyline metabolism and polymorphic debrisoquine hydroxylation in native Chinese volunteers]. Zhang XH, Yu P, Gu NF, Yin JL, Jiang WD. Yao Xue Xue Bao; 1993 Dec 15; 28(2):85-91. PubMed ID: 8328289 [Abstract] [Full Text] [Related]
37. Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms. Dahl ML, Llerena A, Bondesson U, Lindström L, Bertilsson L. Br J Clin Pharmacol; 1994 Jan 15; 37(1):71-4. PubMed ID: 8148222 [Abstract] [Full Text] [Related]
38. Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings]. Andoh B, Idle JR, Mahgoub A, Sloan TP, Smith RL, Woolhouse N. Br J Pharmacol; 1979 Jul 15; 66(3):431P. PubMed ID: 526720 [No Abstract] [Full Text] [Related]